NEW YORK – 14 September, 2026 – Alpha Omega Peptide, a supplier of research-use peptides to laboratory and academic research buyers, today announced third-party purity testing and expanded sourcing disclosure across its full product catalog. The company will publish an independent certificate of analysis for every batch sold, alongside sourcing documentation identifying the raw material supply chain behind each product. The change applies to the entire current catalog, not a limited pilot set of items.
The research peptide supply chain has drawn scrutiny for years over inconsistent labeling and variable purity between suppliers, with buyers frequently unable to verify what a vial actually contains once it ships. Academic and laboratory purchasers have had to rely on supplier-provided documentation with no independent check behind it, a gap that has shaped how research institutions vet vendors before ordering. Third-party verification, rather than in-house testing alone, has become the baseline researchers ask for before treating a supplier as credible.
A spokesperson for Alpha Omega Peptide said the standard was overdue for the category. “Researchers should not have to take a supplier’s word for what is in a vial,” the Alpha Omega Peptide team said. “Independent verification on every batch is the only way to make purity claims mean something.”
Third-party testing on every batch
Each product now carries a certificate of analysis generated by an independent testing lab rather than internal quality control alone. The testing covers purity and identity verification per batch, and the certificate is tied to the specific lot a customer receives rather than a general product-line average. Batch-level testing, as opposed to periodic spot checks, is the distinction research buyers have said matters most when comparing suppliers.
Sourcing disclosure
Alpha Omega Peptide is also publishing sourcing information describing where raw material inputs originate before formulation. Buyers evaluating a research supplier have historically had no way to trace a product’s supply chain, leaving purity claims disconnected from any visibility into how the material was sourced or handled upstream. The company says the disclosure is meant to close that gap rather than serve as a one-time announcement.
Documentation access for buyers
Certificates of analysis and sourcing summaries are being made available to customers directly rather than provided only on request. “Documentation that a customer has to ask for isn’t transparency, it’s a formality,” a spokesperson for Alpha Omega Peptide said. “Every batch gets a certificate, and every customer can see it before and after they order.” The company frames the change as a baseline standard for the category rather than a premium feature tied to specific products.
About Alpha Omega Peptide
Alpha Omega Peptide supplies research-use peptides to laboratory, academic, and institutional research buyers. The company’s current standard applies independent third-party purity testing and published certificates of analysis to every batch across its full catalog, alongside sourcing documentation identifying the raw material supply chain behind each product. Alpha Omega Peptide positions batch-level, buyer-accessible documentation as the operating standard for its catalog going forward. More information is available at alphaomegapeptide.com.
Media Contact
Company Name: Alpha Omega Peptide
Contact Person: Press
Email: Send Email
Phone: (888) 453-0711
Address:6586 W Atlantic Ave Ste #1112
City: Delray Beach
State: FL
Country: United States
Website: https://alphaomegapeptide.com
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Alpha Omega Peptide Adds Batch-Level Purity Testing to Full Catalog
Media gallery
